Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1 Genitourinary 1 Breast 1

Conditions

Breast Neoplasms 13110 Triple Negative Breast Neoplasms 1145 Neoplasms 748 Ovarian Neoplasms 676 Neoplasm Metastasis 588 Lung Neoplasms 581 Colorectal Neoplasms 576 Prostatic Neoplasms 559 Carcinoma, Non-Small-Cell Lung 533 Pancreatic Neoplasms 380 Melanoma 366 Stomach Neoplasms 349 Colonic Neoplasms 330 Motor Activity 285 Breast Neoplasms, Male 285 Carcinoma, Intraductal, Noninfiltrating 277 Uterine Cervical Neoplasms 265 Head and Neck Neoplasms 265 Endometrial Neoplasms 254 Carcinoma, Renal Cell 215 Sarcoma 202 Urinary Bladder Neoplasms 192 Squamous Cell Carcinoma of Head and Neck 190 Lymphedema 190 Breast Carcinoma In Situ 189 Esophageal Neoplasms 188 Brain Neoplasms 183 Fatigue 166 Carcinoma, Ovarian Epithelial 151 Breast Cancer Female 148

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Orgasm × Breast × Clear all

NCT01724242 2017-11-28

Vaginal DHEA for Women After Breast Cancer

Hadassah Medical Organization

Phase 2/3 Withdrawn

Breast Neoplasms, Orgasm, Urinary Incontinence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡